Abstract
Technetium-99m labeling of antibodies has been suboptimal because of low affinity adventitious binding, nonspecific labeling, and loss of immunoreactivity. The diamide dithiolate ligand system (N2S2) forms highly stable, well-defined tetradentate complexes with Tc(V). Antibodies and their fragments have been labeled by conjugation of preformed 99mTc-4,5-bis(thioacetamido)pentanoate active ester to protein amine groups to give a chemically known 99mTc-N2S2 complex covalently linked to antibody. Evaluations of the 99mTc-N2S2-bound antibodies and their fragments have shown high stability and retained immunoreactivity.
Full text
PDF




Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Arano Y., Yokoyama A., Magata Y., Saji H., Horiuchi K., Torizuka K. Synthesis and evaluation of a new bifunctional chelating agent for 99mTc labeling proteins: p-carboxyethylphenylglyoxal-di(N-methylthiosemicarbazone). Int J Nucl Med Biol. 1986;12(6):425–430. doi: 10.1016/s0047-0740(86)80003-1. [DOI] [PubMed] [Google Scholar]
- Bradwell A. R., Fairweather D. S., Dykes P. W. Localization of tumours using radiolabelled antibodies. Med Lab Sci. 1984 Jul;41(3):267–278. [PubMed] [Google Scholar]
- Carrasquillo J. A., Abrams P. G., Schroff R. W., Reynolds J. C., Woodhouse C. S., Morgan A. C., Keenan A. M., Foon K. A., Perentesis P., Marshall S. Effect of antibody dose on the imaging and biodistribution of indium-111 9.2.27 anti-melanoma monoclonal antibody. J Nucl Med. 1988 Jan;29(1):39–47. [PubMed] [Google Scholar]
- Carrasquillo J. A., Krohn K. A., Beaumier P., McGuffin R. W., Brown J. P., Hellström K. E., Hellström I., Larson S. M. Diagnosis of and therapy for solid tumors with radiolabeled antibodies and immune fragments. Cancer Treat Rep. 1984 Jan;68(1):317–328. [PubMed] [Google Scholar]
- Childs R. L., Hnatowich D. J. Optimum conditions for labeling of DTPA-coupled antibodies with technetium-99m. J Nucl Med. 1985 Mar;26(3):293–299. [PubMed] [Google Scholar]
- Costello C. E., Brodack J. W., Jones A. G., Davison A., Johnson D. L., Kasina S., Fritzberg A. R. The investigation of radiopharmaceutical components by fast atom bombardment mass spectrometry: the identification of Tc-HIDA and the epimers of Tc-CO2DADS. J Nucl Med. 1983 Apr;24(4):353–355. [PubMed] [Google Scholar]
- Deutsch E., Libson K., Vanderheyden J. L., Ketring A. R., Maxon H. R. The chemistry of rhenium and technetium as related to the use of isotopes of these elements in therapeutic and diagnostic nuclear medicine. Int J Rad Appl Instrum B. 1986;13(4):465–477. doi: 10.1016/0883-2897(86)90027-9. [DOI] [PubMed] [Google Scholar]
- Eckelman W. C., Paik C. H. Comparison of 99mTc and 111In labeling of conjugated antibodies. Int J Rad Appl Instrum B. 1986;13(4):335–343. doi: 10.1016/0883-2897(86)90006-1. [DOI] [PubMed] [Google Scholar]
- Fritzberg A. R. Advances in 99mTc-labeling of antibodies. Nuklearmedizin. 1987 Feb;26(1):7–12. [PubMed] [Google Scholar]
- Hnatowich D. J., Layne W. W., Childs R. L., Lanteigne D., Davis M. A., Griffin T. W., Doherty P. W. Radioactive labeling of antibody: a simple and efficient method. Science. 1983 May 6;220(4597):613–615. doi: 10.1126/science.6836304. [DOI] [PubMed] [Google Scholar]
- Hwang K. M., Fodstad O., Oldham R. K., Morgan A. C., Jr Radiolocalization of xenografted human malignant melanoma by a monoclonal antibody (9.2.27) to a melanoma-associated antigen in nude mice. Cancer Res. 1985 Sep;45(9):4150–4155. [PubMed] [Google Scholar]
- Hwang K. M., Keenan A. M., Frincke J., David G., Pearson J., Oldham R. K., Morgan A. C., Jr Dynamic interaction of 111indium-labeled monoclonal antibodies with surface antigens of solid tumors visualized in vivo by external scintigraphy. J Natl Cancer Inst. 1986 May;76(5):849–855. [PubMed] [Google Scholar]
- Kasina S., Fritzberg A. R., Johnson D. L., Eshima D. Tissue distribution properties of technetium-99m-diamide-dimercaptide complexes and potential use as renal radiopharmaceuticals. J Med Chem. 1986 Oct;29(10):1933–1940. doi: 10.1021/jm00160a023. [DOI] [PubMed] [Google Scholar]
- Larson S. M. Radiolabeled monoclonal anti-tumor antibodies in diagnosis and therapy. J Nucl Med. 1985 May;26(5):538–545. [PubMed] [Google Scholar]
- Morgan A. C., Jr, Galloway D. R., Reisfeld R. A. Production and characterization of monoclonal antibody to a melanoma specific glycoprotein. Hybridoma. 1981;1(1):27–36. doi: 10.1089/hyb.1.1981.1.27. [DOI] [PubMed] [Google Scholar]
- Paik C. H., Eckelman W. C., Reba R. C. Transchelation of 99mTc from low affinity sites to high affinity sites of antibody. Int J Rad Appl Instrum B. 1986;13(4):359–362. doi: 10.1016/0883-2897(86)90010-3. [DOI] [PubMed] [Google Scholar]
- Petit W. A., DeLand F. H., Pepper G. H., Blanton L. Characterization of tin-technetium colloid in technetium-labeled albumin preparations. J Nucl Med. 1978 Apr;19(4):387–392. [PubMed] [Google Scholar]
- Scheinberg D. A., Strand M., Gansow O. A. Tumor imaging with radioactive metal chelates conjugated to monoclonal antibodies. Science. 1982 Mar 19;215(4539):1511–1513. doi: 10.1126/science.7199757. [DOI] [PubMed] [Google Scholar]
- Thielemans K., Maloney D. G., Meeker T., Fujimoto J., Doss C., Warnke R. A., Bindl J., Gralow J., Miller R. A., Levy R. Strategies for production of monoclonal anti-idiotype antibodies against human B cell lymphomas. J Immunol. 1984 Jul;133(1):495–501. [PubMed] [Google Scholar]
- Tveit K. M., Fodstad O., Johannessen J. V., Olsnes S. A human melanoma cell line established from xenograft in athymic mice. Br J Cancer. 1980 May;41(5):724–733. doi: 10.1038/bjc.1980.134. [DOI] [PMC free article] [PubMed] [Google Scholar]